Literature DB >> 4347296

Treatment of myasthenia gravis.

W Flacke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4347296     DOI: 10.1056/NEJM197301042880107

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

2.  Congenital and hereditary myasthenia.

Authors:  R Palencia; F Hermoso; A Blanco; E Sanchez Villares
Journal:  Eur J Pediatr       Date:  1982-07       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.